BNR
Burning Rock Biotech Ltd.
NASDAQ · Healthcare · Medical - Diagnostics & Research · CN
$13.29
+21.48%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.65x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.88x
- Price / sales
- 1.87x
- Price / cash flow
- -76.55x
Enterprise value
- Enterprise value
- $84.1M
- EV / sales
- 1.12x
- EV / EBITDA
- -13.30x
- EV / EBIT
- -8.64x
- Market cap
- $140.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026